You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 21, December 1, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Randomized, Controlled Trial of Clonidine for Smoking Cessation in a Primary Care Setting

Peter Franks, MD; Jeffrey Harp, MD; Beth Bell, MD

JAMA. 1989;262(21):3011-3013.


Abstract

Clonidine hydrochloride has been reported to reduce tobacco withdrawal symptoms and facilitate smoking cessation. We enrolled 185 subjects, 92 receiving clonidine and 93 receiving placebo, in a randomized, double-blind study of clonidine for smoking cessation in a primary care setting. Clonidine had no demonstrable effect on withdrawal (8 of 11 measures favoring placebo). At 4 weeks, 17 (18%) subjects receiving clonidine had quit compared with 13 (14%) receiving placebo ({chi}2 = 0.7; 90% confidence interval of benefit from clonidine, —4% to 13%). At 4 weeks, the mean number of cigarettes smoked was 17.7 for those receiving clonidine and 17.5 for those receiving placebo (t=0.1; 90% confidence interval of benefit from clonidine, —4.1 to 3.7 cigarettes per day). These results provide little support for a beneficial effect of clonidine on tobacco withdrawal symptoms, quitting, or smoking reduction in a primary care setting.

(JAMA. 1989;262:3011-3013)



Author Affiliations

From the Department of Family Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY.


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An Analysis of the Effectiveness of Interventions Intended to Help People Stop Smoking
Law and Tang
Arch Intern Med 1995;155:1933-1941.
ABSTRACT  

Cigarette Smoking, Nicotine Addiction, and Its Pharmacologic Treatment
Lee and D'Alonzo
Arch Intern Med 1993;153:34-48.
ABSTRACT  

Transdermal Clonidine Reduced Some Withdrawal Symptoms but Did not Increase Smoking Cessation
Prochazka et al.
Arch Intern Med 1992;152:2065-2069.
ABSTRACT  

Smoking Cessation: Putting Prevention Into Practice
Houston
Arch Fam Med 1992;1:128-135.
ABSTRACT  

A Trial of Clonidine to Stop Smoking
Lucas
JAMA 1990;263:2746-2746.
ABSTRACT  

A Trial of Clonidine to Stop Smoking
Mark
JAMA 1990;263:2746-2746.
ABSTRACT  

A Trial of Clonidine to Stop Smoking
Ornish
JAMA 1990;263:2746-2747.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.